European Bank for iPSCs

Exciting news for researchers in Oceania! CellBank Australia is now the official distributor of EBiSC iPSC lines — giving local access to 950+ high-quality lines across 45+ disease areas.

🔗 Order via CellBank: www.cellbankaustralia.com/cell-lines-f...

#iPSC #EBiSC #StemCells #BiomedicalResearch

Enriching iPSC research diversity: Harnessing human biobank collections for improved ethnic representation - PubMed Biobanks of human biosamples and cell lines are indispensable for biomedical research on human health and disease and for drug development projects. Many human cell line biobanks worldwide hold collections of lymphoblastoid cell lines (LCLs), representing thousands of affected and control donors fro …

New publication on improving ancestral diversity in iPSC research!

EBiSC has curated a panel of control iPSC lines from diverse backgrounds — now available to researchers — and welcomes donation of new lines to help make iPSC resources more inclusive.

🔗 pubmed.ncbi.nlm.nih.gov/38943497/

#iPSC

That’s a wrap on ELRIG Drug Discovery 2025! Special thanks to all who came to share their research with us. If you still want to share your data with EBiSC, it’s not too late! Just get in touch and we can help disseminate your research.

#ELRIG #iPSC #Research

🎉 Today marks the start of ELRIG Drug Discovery 2025 in the wonderful Liverpool.

We want to see the amazing science being done with EBiSC iPSC lines. If you’re presenting data either on a poster or in a talk, come to booth G17 to let us know and collect your prize!

#ELRIGDD2025 #iPSC #ELRIG

📢 We’re excited to to be attending ELRIG Drug Discovery 2025 in Liverpool this week!

Our team is looking forward to connecting with researchers - our core goal is to support and enable iPSC research so come and tell us what you need from an iPSC repository!

#ELRIG2025 #DrugDiscovery #iPSCs

How FAIR is metadata for human pluripotent stem cells? In this article, Wells and colleagues present the first systematic FAIR evaluation of stem cell data infrastructures. Case studies from, but not limited to, the United States, Japan, Europe, and Austr...

Great to see EBiSC featured in Stem Cell Reports’ “How FAIR is metadata for human pluripotent stem cells?” — highlighting the importance of FAIR data in iPSC research.

🔗 [https://www.cell.com/stem-cell-reports/fulltext/S2213-6711(25)00248-6]

#iPSC #FAIRData #OpenScience #EBiSC #StemCellResearch

Angelman syndrome is rare (~1 in 15,000) but one of the most *actionable* neurogenetic conditions. Thanks to collaboration between FAST, Yale University & EBiSC, a curated iPSC panel now reflects the full range of AS genotypes.

🔗 ebisc.org/search?q=Yui

#AngelmanSyndrome #iPSC #RareDiseases

📢 Today’s the day! Thrilled to kick off the #UKSCN 2025 meeting in Manchester today.

Looking forward to a packed day of talks and discussions.

If you see our team around, come say hi! 👋

🎉 We're excited for the UK Stem Cell Network Inaugural meeting next week!
Looking forward to great talks, new ideas, and connecting with UK researchers.

Who else is here? Let’s meet up!

#UKSCN #iPSCs #Research #StemCells

ApoE4 disrupts intracellular trafficking and iron homeostasis in a reproducible iPSC-based model of human brain endothelial cells Bell and colleagues develop a new protocol to differentiate brain endothelial cells from iPSC to investigate the regulation of intracellular transport across the blood-brain barrier. They find that Ap...

🧬 New paper in Stem Cell Reports used EBiSC iPSC lines BIONi037-A (ApoE3/E3) and BIONi037-A-4 (ApoE4/E4) to study how APOE genotype impacts cell biology.

Both lines are available via EBiSC👉

(www.cell.com/stem-cell-re...

#iPSC #EBiSC #APOE #Alzheimers

📢 Hello Bluesky!

This is our official account for EBiSC — the European Bank for induced Pluripotent Stem Cells.

We’ll be sharing news on new iPSC lines, publications, data and how we work to enable iPSC science.

Join in the discussion and tell us how we can support you and your research!